
WEGO Medical, a subsidiary of Weigao Group, is a leading medical device manufacturer。WEGO Medical, a subsidiary of Weigao Group
Sodium Citrate 1:9 (3.8%) acts as an anticoagulant in coagulation tests, with a ratio of 1 part anticoagulant to 9 parts blood.
WG03-001-008
Sodium Citrate 1:9 with 3.8%(0.129mol/L) sodium citrate as anticoagulant used for coagulation test and ratio of anticoagulant and blood is 1:9.
The only manufacturer of blood collection tubes withelectron beam irradiation sterilization equipment in Chinawith irradiation dose of about 15-25KGY.
Sodium Citrate 1:9 with 3.2%(0.109mol/L) sodium citrate as anticoagulant used for coagulation test and ratio of anticoagulant and blood is 1:9.
The only manufacturer of blood collection tubes withelectron beam irradiation sterilization equipment in Chinawith irradiation dose of about 15-25KGY.
No small molecule micelles are precipitated, and there is norisk of clogging the probe.
| Materiel | Glass/Plastic |
| Cap Colour | BLUE |
| Reference Number | Tube Size | Volume |
| PN1207518 | 12x75mm | 1.8ml |
| PN1207527 | 12x75mm | 2.7ml |
| Additive status | Liquid |
| Pack/Carton | 100/1800 |

WEGO Medical, a subsidiary of Weigao Group, is a leading medical device manufacturer。WEGO Medical, a subsidiary of Weigao Group

WEGO Medical is pleased to announce its participation in WHX Dubai 2026, formerly known as Arab Health, one of the most influential global healthcare exhibitions.

As the new year begins, WEGO Overseas Group would like to extend our warmest New Year greetings to partners, customers, and colleagues around the world.

From all of us at WEGO, we extend our warmest wishes to our global partners and customers. May this festive season bring joy, peace, and